Merck to expand US biopharmaceutical R & D facility to advance innovative clinical pipeline

Merck, a leading science and technology company, today announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new building will span 145,000 square feet, offering new laboratory and collaborative working space to accommodate approximately 400 new and current R&D employees focused on advancing science in oncology, immuno-oncology and immunology. (Source: World Pharma News)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2RHbA1S